Mini Review
Spiliotis John
Abstract
HIPEC in colorectal malignant growth with peritoneal carcinomatosis studies reveal that the mix of broad cytoreductive medical procedure with hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) has been accounted for to confer a benefit in survival of patients with peritoneal carcinomatosis from colorectal cancer. One investigation demonstrated a middle generally survival of 19.2 months in patients treated with CRS and HIPEC. This review shows all the randomized preliminaries with better standardization of HIPEC procedures in order to develop guidelines concerning the P.C. management.